8-K
filed May 13, 2026, 4:07 PM ET
ticker ELV
CIK 0001156039
other material
confidence high
sentiment neutral
materiality 0.15
Elevance Health annual meeting: directors elected, exec pay approved, shareholder proposal defeated
Elevance Health, Inc.
- Gail K. Boudreaux, Robert L. Dixon Jr., and Deanna D. Strable elected as directors for three-year terms.
- Advisory vote on named executive officer compensation approved with 172.4M for vs 7.2M against.
- Ratification of Ernst & Young as auditor for FY 2026 passed with 175.2M for, 19.1M against.
- Shareholder proposal for independent study on banning corporate 527 political contributions defeated: 15.6M for, 162.9M against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Elevance Health, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
3. Ratification of the appointment of Ernst & Young LLP . The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based upon the following votes: For Against Abstain 175,183,332 19,141,697 116,310
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Elevance Health, Inc. shareholders rejected Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups at the 2026-05-13 meeting.
- Outcome
- failed
- Meeting
- 2026-05-13
Exact text from the filing
4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups. The shareholder proposal requesting a study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups was not approved based upon the following votes: For Against Abstain Broker Non-Votes 15,587,160 162,924,290 1,292,319 14,637,570
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Elevance Health, Inc. shareholders approved Advisory vote on the Company's executive compensation at the 2026-05-13 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
2. Advisory vote on the Company’s executive compensation . The advisory vote on the compensation of the Company’s named executive officers was approved based upon the following votes: For Against Abstain Broker Non-Votes 172,363,616 7,240,619 199,534 14,637,570
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Elevance Health, Inc. shareholders approved Election of Directors at the 2026-05-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
1. Election of Directors . The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2029 based on the following votes: Nominee For Against Abstain Broker Non-Votes Gail K. Boudreaux 177,978,713 1,714,229 110,827 14,637,570 Robert L. Dixon, Jr. 174,098,489 5,590,793 114,487 14,637,570 Deanna D. Strable 175,331,822 4,360,980 110,967 14,637,570
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.